| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9261708 | Autoimmunity Reviews | 2005 | 8 Pages |
Abstract
This review will focus on both new uses for established therapies as well as on the introduction of novel agents. It is premature to claim that any one agent has superior efficacy to current therapies. However, the willingness of investigators supported by the pharmaceutical and biotechnology industries to evaluate the efficacy and safety of new products in controlled clinical trials may provide answers.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Sean Gregory O'Neill, Leslie Schrieber,